Dianeal + Dianeal, Extraneal, Nutrineal
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
End Stage Renal Disease (ESRD)
Conditions
End Stage Renal Disease (ESRD), Diabetes, CAPD
Trial Timeline
Oct 1, 2010 → Jul 1, 2011
NCT ID
NCT01219959About Dianeal + Dianeal, Extraneal, Nutrineal
Dianeal + Dianeal, Extraneal, Nutrineal is a phase 3 stage product being developed by Baxter for End Stage Renal Disease (ESRD). The current trial status is completed. This product is registered under clinical trial identifier NCT01219959. Target conditions include End Stage Renal Disease (ESRD), Diabetes, CAPD.
What happened to similar drugs?
20 of 20 similar drugs in End Stage Renal Disease (ESRD) were approved
Approved (20) Terminated (2) Active (0)
✅Henagliflozin 5 mg Group + Henagliflozin 10 mg Group + Conventional therapy groupJiangsu Hengrui MedicineApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01219959 | Phase 3 | Completed |
Competing Products
20 competing products in End Stage Renal Disease (ESRD)